Industries - Diabetic Foot Ulcer Market Analysis by Treatment (Wound Care Settings, Therapy Devices, Biologics), by Ulcer Type (Ischemic Ulcers, Neuropathic Ulcers, Neuro-ischemic Ulcers), and by Region – Forecast to 2026

Ablation Technology Market Analysis

Diabetic Foot Ulcer Market Analysis by Treatment (Wound Care Settings, Therapy Devices, Biologics), by Ulcer Type (Ischemic Ulcers, Neuropathic Ulcers, Neuro-ischemic Ulcers), and by Region – Forecast to 2026
May 2021

SKU: N/A Category:
Clear
  • Description
  • Additional information
  • Enquire about

Description

Diabetic Foot Ulcer Market Analysis by Treatment (Wound Care Settings, Therapy Devices, Biologics), by Ulcer Type (Ischemic Ulcers, Neuropathic Ulcers, Neuro-ischemic Ulcers), and by Region - Forecast to 2026

Published: May 2021 | Historical Data: 2018-2020 | Base Year: 2020
SKU: ICI-HC-1118 | Number of Pages: 126 | Category: Pharmaceuticals

The global diabetic foot ulcer market size was valued at USD 7,340.2 million in 2020 and is expected to witness a CAGR of 6.9% during the forecast period. Increasing incidence of diabetes coupled with rapidly growing aging population is a key driver for the growth of the global diabetic foot ulcer market. Additionally, growing demand for biologics and government initiatives are some of the other drivers propelling the market growth. However, the high cost of treatment and inadequate medical facilities in developing economies are expected to restrain the global market growth.

Diabetic Foot Ulcer Market Analysis

By Treatment

Based on treatment, the market is segmented into wound care settings, therapy devices, and biologics. In 2020, the biologics segment accounted for the significant revenue share and is expected to show highest CAGR during the forecast period. This is attributed to the escalating demand for biologics instead of surgeries, worldwide. Wound care setting segment held the second largest market share owing to increase in number of diabetic patients suffering from foot ulcers.

By Ulcer Type

Based on ulcer type, the market is categorized into ischemic ulcers, neuropathic ulcers, and neuro-ischemic ulcers. In 2020, the neuro-ischemic ulcers segment accounted for the maximum revenue share due to increasing number of cases worldwide. The neuropathic ulcers segment is anticipated to grow at a steady CAGR during the forecast period, due to the high awareness for neuropathic ulcers.

Regional Insights

In 2020, North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the large diabetic patient pool, advanced healthcare infrastructure, and high investments in R&D in this region. Asia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to the rising old-age population, growing consumer awareness for health, and investments in research & development in this region.

North America Diabetic Foot Ulcer Market Size (2018-2026), USD Million

North America Diabetic Foot Ulcer Market

Competitor Insights

Some of the key players in the diabetic foot ulcer market are Mölnlycke Health Care AB (Sweden); Organogenesis Inc. (U.S.); Medtronic plc (U.S.); B. Braun Holding GmbH & Co. KG (Germany); Smith & Nephew plc (U.K.); Coloplast A/S (Denmark); 3M Company (U.S.); Medline Industries, Inc. (U.S.); Acelity L.P. Inc. (U.S.); and ConvaTec Group plc (U.K.). The leading players operating in the diabetic foot ulcer market are adopting various strategies including new product launches, development of advanced diagnostic techniques, mergers & acquisitions, and regional expansions to capture a maximum revenue share.

 

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2018 to 2026. The diabetic foot ulcer market report is categorized into the following segments and subsegments:

Diabetic Foot Ulcer Market, By Treatment (Revenue, USD Million, 2018 – 2026)

  • Wound Care Dressings
    • Hydrofiber Dressings
    • Alginate Dressings
    • Hydrogel Dressings
    • Foam Dressings
    • Hydrocolloid Dressings
    • Film Dressing
    • Surgical Dressings
  • Therapy Devices
    • Ultrasound Therapy
    • Negative Pressure Wound Therapy
    • Antibiotic Medications
    • Others
  • Biologics
    • Skin Grafts
    • Growth Factors

Diabetic Foot Ulcer Market, By Ulcer Type (Revenue, USD Million, 2018 – 2026)

  • Ischemic Ulcers
  • Neuropathic Ulcers
  • Neuro-ischemic Ulcers

Diabetic Foot Ulcer Market, By Region (Revenue, USD Million, 2018 – 2026)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Scope of Diabetic Foot Ulcer Market Report:

Key Parameters Details
Data Availability 2018-2026
Historical Years 2018-2020
Base Year Considered 2020
Forecast Period 2020-2026
Company Profiles 10
Companies Considered >40
Value Units Value in USD and CAGR in %
Market Segments Treatment and Ulcer Type
Regional Coverage North America (U.S. and Canada), Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina, Rest of LATAM), and the Middle East & Africa (South Africa, Saudi Arabia, Rest of MEA)
Key Market Players Mölnlycke Health Care AB (Sweden); Organogenesis Inc. (U.S.); Medtronic plc (U.S.); B. Braun Holding GmbH & Co. KG (Germany); Smith & Nephew plc (U.K.); Coloplast A/S (Denmark); 3M Company (U.S.); Medline Industries, Inc. (U.S.); Acelity L.P. Inc. (U.S.); and ConvaTec Group plc (U.K.)
Custom Analysis Customization up to 60 analyst hours

Diabetic Foot Ulcer Market, By Treatment (Revenue, USD Million, 2018 – 2026)

  • Wound Care Dressings
    • Hydrofiber Dressings
    • Alginate Dressings
    • Hydrogel Dressings
    • Foam Dressings
    • Hydrocolloid Dressings
    • Film Dressing
    • Surgical Dressings
  • Therapy Devices
    • Ultrasound Therapy
    • Negative Pressure Wound Therapy
    • Antibiotic Medications
    • Others
  • Biologics
    • Skin Grafts
    • Growth Factors

Diabetic Foot Ulcer Market, By Ulcer Type (Revenue, USD Million, 2018 – 2026)

  • Ischemic Ulcers
  • Neuropathic Ulcers
  • Neuro-ischemic Ulcers

Diabetic Foot Ulcer Market, By Region (Revenue, USD Million, 2018 – 2026)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA
1. Research Methodology
 1.1. Research Objective
 1.2. Study Scope: Market Segments
 1.3. Study Timeframe, Limitations & Currency
 1.4. Domain-Assisted Cognition (DAC) Framework
  1.4.1. Three-stage Research Methodology
   1.4.1.1. Understand Ecosystem
    1.4.1.1.1. Secondary Research
    1.4.1.1.2. Primary Research
    1.4.1.1.3. Internal Repository
   1.4.1.2. Synthesize Information
    1.4.1.2.1. Data Analysis
    1.4.1.2.2. Data Triangulation
   1.4.1.3. Predict/Project Growth
    1.4.1.3.1. Market Size Estimation
     1.4.1.3.1.1. Bottom-up Approach
     1.4.1.3.1.2. Top-down Approach
    1.4.1.3.2. Data Validation
  1.4.2. Two-stage Quality Check Mechanism
   1.4.2.1. Inspection & Reporting
   1.4.2.2. Quality Audit
2. Market Summary
 2.1. Market Definition & Market Landscape
 2.2. Market Segment Snapshot
 2.3. Geographic Market Snapshot
3. Market Dynamics
 3.1. Market Driver Analysis
  3.1.1. Increasing incidences of diabetes cases
  3.1.2. Rapidly growing old-age population
  3.1.3. Advancements in Technology
  3.1.4. Government initiatives
 3.2. Market Restraint Analysis
  3.2.1. High cost of treatment
  3.2.2. Inadequate medical facilities in developing economies
 3.3. Market Opportunities
  3.3.1. Novel product development
  3.3.2. Increasing medical expenditure by consumers in developing economies
4. Industry Outlook
 4.1. Key Market Trends
 4.2. Value Chain Analysis
 4.3. Porter’s 5 Forces Analysis
 4.4. Pricing Analysis (2018-2020)
 4.5. Product Benchmarking
5. Covid-19 Impact and Deviation Analysis
 5.1. Covid-19 Prevalence Analysis
 5.2. Key Market Trends
 5.3. Market Size Deviation Analysis (2020-2026)
6. Diabetic Foot Ulcer Market Size and Forecast, by Treatment (2018-2026), USD Million
 6.1. Wound Care Dressings
  6.1.1. Hydrofiber Dressings
  6.1.2. Alginate Dressings
  6.1.3. Hydrogel Dressings
  6.1.4. Foam Dressings
  6.1.5. Hydrocolloid Dressings
  6.1.6. Film Dressing
  6.1.7. Surgical Dressings
 6.2. Therapy Devices
  6.2.1. Ultrasound Therapy
  6.2.2. Negative Pressure Wound Therapy
  6.2.3. Antibiotic Medications
  6.2.4. Others
 6.3. Biologics
  6.3.1. Skin Grafts
  6.3.2. Growth Factors
7. Diabetic Foot Ulcer Market Size and Forecast, by Ulcer Type (2018-2026), USD Million
 7.1. Ischemic Ulcers
 7.2. Neuropathic Ulcers
 7.3. Neuro-ischemic Ulcers
8. Diabetic Foot Ulcer Market, Regional Analysis (2018-2026), USD Million
 8.1. North America
  8.1.1. Introduction
   8.1.1.1. Market Size & Forecast, by Treatment (2018-2026), USD Million
   8.1.1.2. Market Size & Forecast, by Ulcer Type (2018-2026), USD Million
   8.1.1.3. Market Size & Forecast, by Country (2018-2026), USD Million
  8.1.2. U.S.
   8.1.2.1. Market Size & Forecast, by Treatment (2018-2026), USD Million
   8.1.2.2. Market Size & Forecast, by Ulcer Type (2018-2026), USD Million
  8.1.3. Canada
   8.1.3.1. Market Size & Forecast, by Treatment (2018-2026), USD Million
   8.1.3.2. Market Size & Forecast, by Ulcer Type (2018-2026), USD Million
 8.2. Europe
  8.2.1. Introduction
   8.2.1.1. Market Size & Forecast, by Treatment (2018-2026), USD Million
   8.2.1.2. Market Size & Forecast, by Ulcer Type (2018-2026), USD Million
   8.2.1.3. Market Size & Forecast, by Country (2018-2026), USD Million
  8.2.2. Germany
   8.2.2.1. Market Size & Forecast, by Treatment (2018-2026), USD Million
   8.2.2.2. Market Size & Forecast, by Ulcer Type (2018-2026), USD Million
  8.2.3. UK
   8.2.3.1. Market Size & Forecast, by Treatment (2018-2026), USD Million
   8.2.3.2. Market Size & Forecast, by Ulcer Type (2018-2026), USD Million
  8.2.4. France
   8.2.4.1. Market Size & Forecast, by Treatment (2018-2026), USD Million
   8.2.4.2. Market Size & Forecast, by Ulcer Type (2018-2026), USD Million
  8.2.5. Spain
   8.2.5.1. Market Size & Forecast, by Treatment (2018-2026), USD Million
   8.2.5.2. Market Size & Forecast, by Ulcer Type (2018-2026), USD Million
  8.2.6. Italy
   8.2.6.1. Market Size & Forecast, by Treatment (2018-2026), USD Million
   8.2.6.2. Market Size & Forecast, by Ulcer Type (2018-2026), USD Million
  8.2.7. Russia
   8.2.7.1. Market Size & Forecast, by Treatment (2018-2026), USD Million
   8.2.7.2. Market Size & Forecast, by Ulcer Type (2018-2026), USD Million
  8.2.8. Rest of Europe
   8.2.8.1. Market Size & Forecast, by Treatment (2018-2026), USD Million
   8.2.8.2. Market Size & Forecast, by Ulcer Type (2018-2026), USD Million
 8.3. Asia Pacific (APAC)
  8.3.1. Introduction
   8.3.1.1. Market Size & Forecast, by Treatment (2018-2026), USD Million
   8.3.1.2. Market Size & Forecast, by Ulcer Type (2018-2026), USD Million
   8.3.1.3. Market Size & Forecast, by Country (2018-2026), USD Million
  8.3.2. China
   8.3.2.1. Market Size & Forecast, by Treatment (2018-2026), USD Million
   8.3.2.2. Market Size & Forecast, by Ulcer Type (2018-2026), USD Million
  8.3.3. Japan
   8.3.3.1. Market Size & Forecast, by Treatment (2018-2026), USD Million
   8.3.3.2. Market Size & Forecast, by Ulcer Type (2018-2026), USD Million
  8.3.4. India
   8.3.4.1. Market Size & Forecast, by Treatment (2018-2026), USD Million
   8.3.4.2. Market Size & Forecast, by Ulcer Type (2018-2026), USD Million
  8.3.5. Australia
   8.3.5.1. Market Size & Forecast, by Treatment (2018-2026), USD Million
   8.3.5.2. Market Size & Forecast, by Ulcer Type (2018-2026), USD Million
  8.3.6. South Korea
   8.3.6.1. Market Size & Forecast, by Treatment (2018-2026), USD Million
   8.3.6.2. Market Size & Forecast, by Ulcer Type (2018-2026), USD Million
  8.3.7. Rest of Asia Pacific
   8.3.7.1. Market Size & Forecast, by Treatment (2018-2026), USD Million
   8.3.7.2. Market Size & Forecast, by Ulcer Type (2018-2026), USD Million
 8.4. Latin America (LATAM)
  8.4.1. Introduction
   8.4.1.1. Market Size & Forecast, by Treatment (2018-2026), USD Million
   8.4.1.2. Market Size & Forecast, by Ulcer Type (2018-2026), USD Million
   8.4.1.3. Market Size & Forecast, by Country (2018-2026), USD Million
  8.4.2. Brazil
   8.4.2.1. Market Size & Forecast, by Treatment (2018-2026), USD Million
   8.4.2.2. Market Size & Forecast, by Ulcer Type (2018-2026), USD Million
  8.4.3. Mexico
   8.4.3.1. Market Size & Forecast, by Treatment (2018-2026), USD Million
   8.4.3.2. Market Size & Forecast, by Ulcer Type (2018-2026), USD Million
  8.4.4. Argentina
   8.4.4.1. Market Size & Forecast, by Treatment (2018-2026), USD Million
   8.4.4.2. Market Size & Forecast, by Ulcer Type (2018-2026), USD Million
  8.4.5. Rest of LATAM
   8.4.5.1. Market Size & Forecast, by Treatment (2018-2026), USD Million
   8.4.5.2. Market Size & Forecast, by Ulcer Type (2018-2026), USD Million
 8.5. Middle East & Africa (MEA)
  8.5.1. Introduction
   8.5.1.1. Market Size & Forecast, by Treatment (2018-2026), USD Million
   8.5.1.2. Market Size & Forecast, by Ulcer Type (2018-2026), USD Million
   8.5.1.3. Market Size & Forecast, by Country (2018-2026), USD Million
  8.5.2. South Africa
   8.5.2.1. Market Size & Forecast, by Treatment (2018-2026), USD Million
   8.5.2.2. Market Size & Forecast, by Ulcer Type (2018-2026), USD Million
  8.5.3. Saudi Arabia
   8.5.3.1. Market Size & Forecast, by Treatment (2018-2026), USD Million
   8.5.3.2. Market Size & Forecast, by Ulcer Type (2018-2026), USD Million
  8.5.4. Rest of MEA
   8.5.4.1. Market Size & Forecast, by Treatment (2018-2026), USD Million
   8.5.4.2. Market Size & Forecast, by Ulcer Type (2018-2026), USD Million
9. Competitor Analysis
 9.1. Market Player Comparison
 9.2. Product-wise Player Mapping
 9.3. Region-wise Player Mapping
 9.4. Market Share Analysis
 9.5. Market Position Analysis
 9.6. Recent Development Analysis
10. Company Profiles
 10.1. Mölnlycke Health Care AB (Sweden)
  10.1.1. Company Overview
  10.1.2. Company Financials
  10.1.3. Product Portfolio
  10.1.4. Recent Developments
 10.2. Organogenesis Inc. (U.S.)
  10.2.1. Company Overview
  10.2.2. Company Financials
  10.2.3. Product Portfolio
  10.2.4. Recent Developments
 10.3. Medtronic plc (U.S.)
  10.3.1. Company Overview
  10.3.2. Company Financials
  10.3.3. Product Portfolio
  10.3.4. Recent Developments
 10.4. B. Braun Holding GmbH & Co. KG (Germany)
  10.4.1. Company Overview
  10.4.2. Company Financials
  10.4.3. Product Portfolio
  10.4.4. Recent Developments
 10.5. Smith & Nephew plc (U.K.)
  10.5.1. Company Overview
  10.5.2. Company Financials
  10.5.3. Product Portfolio
  10.5.4. Recent Developments
 10.6. Coloplast A/S (Denmark)
  10.6.1. Company Overview
  10.6.2. Company Financials
  10.6.3. Product Portfolio
  10.6.4. Recent Developments
 10.7. 3M Company (U.S.)
  10.7.1. Company Overview
  10.7.2. Company Financials
  10.7.3. Product Portfolio
  10.7.4. Recent Developments
 10.8. Medline Industries, Inc. (U.S.)
  10.8.1. Company Overview
  10.8.2. Company Financials
  10.8.3. Product Portfolio
  10.8.4. Recent Developments
 10.9. Acelity L.P. Inc. (U.S.)
  10.9.1. Company Overview
  10.9.2. Company Financials
  10.9.3. Product Portfolio
  10.9.4. Recent Developments
 10.10. ConvaTec Group plc (U.K.)
  10.10.1. Company Overview
  10.10.2. Company Financials
  10.10.3. Product Portfolio
  10.10.4. Recent Developments
(Note: Financials are captured for public listed companies)

Key questions addressed by the research report-

  1. What are the current market trends and future market forecast from 2020 to 2026 for diabetic foot ulcer market?
  2. What are the market dynamics and probable opportunities for market players during the forecast period?
  3. Initiatives undertaken by market players to address the COVID-19 impact to sustain in the competitive market
  4. Which geographies have immense opportunities in different segments of the diabetic foot ulcer market?
  5. What are the recent strategies adopted by market players such as product launch, partnership, agreement, collaboration, merger & acquisition, and geographical expansion?


    Have any question? Check your free sample before purchase or connect with our expert.

    Additional information

    Licensing Types

    , , ,

    Enquire about Diabetic Foot Ulcer Market Analysis by Treatment (Wound Care Settings, Therapy Devices, Biologics), by Ulcer Type (Ischemic Ulcers, Neuropathic Ulcers, Neuro-ischemic Ulcers), and by Region - Forecast to 2026